Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Matsoukas

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Current Medicinal Chemistry|June 25, 2005
Structural requirements for binding of myelin basic protein (MBP) peptides to MHC II: effects on immune regulationE D Mantzourani, T M Mavromoustakos, J A Platts, et al.
Journal of Medicinal Chemistry|June 1, 1985
Synthesis and biological activities of analogues of angiotensins II and III containing O-methyltyrosine and D-tryptophanJ M Matsoukas, M H Goghari, M N Scanlon, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2000
Structural comparison between type I and type II antagonists: possible implications in the drug design of AT1 antagonistsP Roumelioti, T Tselios, K Alexopoulos, et al.
The Journal of Biological Chemistry|February 18, 1994
Role of the NH2-terminal domain of angiotensin II (ANG II) and [Sar1]angiotensin II on conformation and activity. NMR evidence for aromatic ring clustering and peptide backbone folding compared with [des-1,2,3]angiotensin IIJ M Matsoukas, J Hondrelis, M Keramida, et al.
Journal of Medicinal Chemistry|September 2, 1994
Novel synthesis of cyclic amide-linked analogues of angiotensins II and IIIJ M Matsoukas, J Hondrelis, G Agelis, et al.
Journal of Molecular Graphics & Modelling|November 29, 2005
A putative bioactive conformation for the altered peptide ligand of myelin basic protein and inhibitor of experimental autoimmune encephalomyelitis [Arg91, Ala96] MBP87-99E D Mantzourani, T V Tselios, S Golic Grdadolnik, et al.
Journal of Medicinal Chemistry|April 2, 1993
Synthesis and biological activities of angiotensin II, Sarilesin, and Sarmesin analogues containing Aze or Pip at position 7J M Matsoukas, G Agelis, J Hondrelis, et al.
Journal of Medicinal Chemistry|August 30, 1996
Synthesis and contractile activities of cyclic thrombin receptor-derived peptide analogues with a Phe-Leu-Leu-Arg motif: importance of the Phe/Arg relative conformation and the primary amino group for activityJ M Matsoukas, D Panagiotopoulos, M Keramida, et al.
Journal of Molecular Recognition : JMR|December 1, 1994
Receptor interactions of the position 4 side chains of angiotensin II analogues: importance of aromatic ring quadrupoleG J Moore, R C Ganter, J M Matsoukas, et al.
Journal of Medicinal Chemistry|April 10, 1999
Design and synthesis of a potent cyclic analogue of the myelin basic protein epitope MBP72-85: importance of the Ala81 carboxyl group and of a cyclic conformation for induction of experimental allergic encephalomyelitisT Tselios, L Probert, I Daliani, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Current Medicinal Chemistry|June 25, 2005
Structural requirements for binding of myelin basic protein (MBP) peptides to MHC II: effects on immune regulationE D Mantzourani, T M Mavromoustakos, J A Platts, et al.
Journal of Medicinal Chemistry|June 1, 1985
Synthesis and biological activities of analogues of angiotensins II and III containing O-methyltyrosine and D-tryptophanJ M Matsoukas, M H Goghari, M N Scanlon, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2000
Structural comparison between type I and type II antagonists: possible implications in the drug design of AT1 antagonistsP Roumelioti, T Tselios, K Alexopoulos, et al.
The Journal of Biological Chemistry|February 18, 1994
Role of the NH2-terminal domain of angiotensin II (ANG II) and [Sar1]angiotensin II on conformation and activity. NMR evidence for aromatic ring clustering and peptide backbone folding compared with [des-1,2,3]angiotensin IIJ M Matsoukas, J Hondrelis, M Keramida, et al.
Journal of Medicinal Chemistry|September 2, 1994
Novel synthesis of cyclic amide-linked analogues of angiotensins II and IIIJ M Matsoukas, J Hondrelis, G Agelis, et al.
Journal of Molecular Graphics & Modelling|November 29, 2005
A putative bioactive conformation for the altered peptide ligand of myelin basic protein and inhibitor of experimental autoimmune encephalomyelitis [Arg91, Ala96] MBP87-99E D Mantzourani, T V Tselios, S Golic Grdadolnik, et al.
Journal of Medicinal Chemistry|April 2, 1993
Synthesis and biological activities of angiotensin II, Sarilesin, and Sarmesin analogues containing Aze or Pip at position 7J M Matsoukas, G Agelis, J Hondrelis, et al.
Journal of Medicinal Chemistry|August 30, 1996
Synthesis and contractile activities of cyclic thrombin receptor-derived peptide analogues with a Phe-Leu-Leu-Arg motif: importance of the Phe/Arg relative conformation and the primary amino group for activityJ M Matsoukas, D Panagiotopoulos, M Keramida, et al.
Journal of Molecular Recognition : JMR|December 1, 1994
Receptor interactions of the position 4 side chains of angiotensin II analogues: importance of aromatic ring quadrupoleG J Moore, R C Ganter, J M Matsoukas, et al.
Journal of Medicinal Chemistry|April 10, 1999
Design and synthesis of a potent cyclic analogue of the myelin basic protein epitope MBP72-85: importance of the Ala81 carboxyl group and of a cyclic conformation for induction of experimental allergic encephalomyelitisT Tselios, L Probert, I Daliani, et al.
Pageof 3